DOSSIER · 13F Holders · Q3 2026
CONTINEUM THERAPEUTICS INC
3 institutions still hold CONTINEUM THERAPEUTICS INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 21217B950·3 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
3 institutions reported CONTINEUM THERAPEUTICS INC in Q3 2026. Birchview Capital, LP leads at 99.4% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.